Lv2
168 积分 2026-03-15 加入
From RAS inhibitor resistance to rational combination strategies
2天前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
2个月前
已完结
ADAM9: an updated view of its biology and pathology
3个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
3个月前
已完结
Evolving Treatments and Resistance Mechanisms in Prostate Cancer Therapeutics
4个月前
已完结
Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis
5个月前
已完结
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
5个月前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
5个月前
已完结
皖公网安备34019202002308
